Nrx Pharmaceuticals Stock In The News

NRXP Stock  USD 1.31  0.02  1.55%   
Our overall analysis of NRX Pharmaceuticals' news coverage and content from conventional and social sources shows investors' bearish mood towards NRX Pharmaceuticals. The specific impact of NRX Pharmaceuticals news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of NRX Pharmaceuticals' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using NRX Pharmaceuticals headlines in addition to utilizing other, more conventional financial analysis modules. Check out NRX Pharmaceuticals Backtesting and NRX Pharmaceuticals Hype Analysis.
To learn how to invest in NRX Stock, please use our How to Invest in NRX Pharmaceuticals guide.

NRX Pharmaceuticals Today Top News and Investor Outlook

Yahoo News
11 Most Promising Psychedelic Stocks According to Hedge Funds
https://finance.yahoo.com/news/11-most-promising-psychedelic-stocks-191534615.html
 Neutral
Macroaxis News: globenewswire.com
NRXP ALERT: Levi & Korsinsky, LLP Announces an Investigation into the Fairness of NRx Pharmaceuticals Inc.'s De-SPAC Merger
https://www.globenewswire.com/news-release/2023/07/18/2706803/3080/en/NRXP-ALERT-Levi-Korsinsky-LLP-Announces-an-Investigation-into-the-Fairness-of-NRx-Pharmaceuticals-Inc-s-De-SPAC-Merger.html
 Neutral
Macroaxis News: globenewswire.com
STOCKHOLDER ALERT: Kaskela Law LLC Annou...
https://www.globenewswire.com/news-release/2023/07/10/2701913/0/en/STOCKHOLDER-ALERT-Kaskela-Law-LLC-Announces-Investigation-of-NRx-Pharmaceuticals-Inc-and-Encourages-Long-Term-NRXP-BRPA-Investors-to-Contact-the-Firm.html
 Bullish
Macroaxis News: globenewswire.com
NRXP ALERT: Levi & Korsinsky, LLP Announces an Investigation into the Fairness of NRx Pharmaceuticals Inc.'s De-SPAC Merger
https://www.globenewswire.com/news-release/2023/06/29/2697247/3080/en/NRXP-ALERT-Levi-Korsinsky-LLP-Announces-an-Investigation-into-the-Fairness-of-NRx-Pharmaceuticals-Inc-s-De-SPAC-Merger.html
 Neutral
Macroaxis News: globenewswire.com
NRx Pharmaceuticals、Lotus Pharmaceuticals 和 Alvogen Inc. 宣布合作开发和商业化 NRX-101
https://www.globenewswire.com/news-release/2023/06/06/2683397/0/zh-hans/NRx-Pharmaceuticals-Lotus-Pharmaceuticals-%E5%92%8C-Alvogen-Inc-%E5%AE%A3%E5%B8%83%E5%90%88%E4%BD%9C%E5%BC%80%E5%8F%91%E5%92%8C%E5%95%86%E4%B8%9A%E5%8C%96-NRX-101.html
 Neutral
Macroaxis News: globenewswire.com
NRx Pharmaceuticals, Lotus Pharmaceuticals und Alvogen Inc. kündigen Zusammenarbeit zur Entwicklung und Vermarktung von NRX-101 an
https://www.globenewswire.com/news-release/2023/06/06/2683397/0/de/NRx-Pharmaceuticals-Lotus-Pharmaceuticals-und-Alvogen-Inc-k%C3%BCndigen-Zusammenarbeit-zur-Entwicklung-und-Vermarktung-von-NRX-101-an.html
 Bearish
Macroaxis News: globenewswire.com
NRx Pharmaceuticals, Lotus Pharmaceuticals, dan Alvogen Inc. Mengumumkan Kolaborasi untuk Mengembangkan dan Mengomersialkan NRX-101
https://www.globenewswire.com/news-release/2023/06/06/2683397/0/id/NRx-Pharmaceuticals-Lotus-Pharmaceuticals-dan-Alvogen-Inc-Mengumumkan-Kolaborasi-untuk-Mengembangkan-dan-Mengomersialkan-NRX-101.html
 Neutral
Macroaxis News: globenewswire.com
NRxファーマシューティカルズ (NRx Pharmaceuticals)、ロータス・ファーマシューティカルズ (Lotus Pharmaceuticals)、およびアルボジェン (Alvogen Inc.) がNRX-101の開発・商品化に向けた提携を発表
https://www.globenewswire.com/news-release/2023/06/06/2683397/0/ja/NRx%E3%83%95%E3%82%A1%E3%83%BC%E3%83%9E%E3%82%B7%E3%83%A5%E3%83%BC%E3%83%86%E3%82%A3%E3%82%AB%E3%83%AB%E3%82%BA-NRx-Pharmaceuticals-%E3%83%AD%E3%83%BC%E3%82%BF%E3%82%B9-%E3%83%95%E3%82%A1%E3%83%BC%E3%83%9E%E3%82%B7%E3%83%A5%E3%83%BC%E3%83%86%E3%82%A3%E3%82%AB%E3%83%AB%E3%82%BA-Lotus-Pharmaceuticals-%E3%81%8A%E3%82%88%E3%81%B3%E3%82%A2%E3%83%AB%E3%83%9C%E3%82%B8%E3%82%A7%E3%83%B3-Alvogen-Inc-%E3%81%8CNRX-101%E3%81%AE%E9%96%8B%E7%99%BA-%E5%95%86%E5%93%81%E5%8C%96%E3%81%AB%E5%90%91%E3%81%91%E3%81%9F%E6%8F%90%E6%90%BA%E3%82%92%E7%99%BA%E8%A1%A8.html
 Bearish
Macroaxis News: globenewswire.com
NRx Pharmaceuticals, Lotus Pharmaceuticals y Alvogen Inc. anuncian colaboración para desarrollar y comercializar NRX-101
https://www.globenewswire.com/news-release/2023/06/06/2683397/0/es/NRx-Pharmaceuticals-Lotus-Pharmaceuticals-y-Alvogen-Inc-anuncian-colaboraci%C3%B3n-para-desarrollar-y-comercializar-NRX-101.html
 Neutral
Macroaxis News: globenewswire.com
NRx Pharmaceuticals, Lotus Pharmaceuticals และ Alvogen Inc. ประกาศความร่วมมือเพื่อพัฒนาและนำ NRX-101 เข้าสู่ตลาด
https://www.globenewswire.com/news-release/2023/06/06/2683397/0/th/NRx-Pharmaceuticals-Lotus-Pharmaceuticals-%E0%B9%81%E0%B8%A5%E0%B8%B0-Alvogen-Inc-%E0%B8%9B%E0%B8%A3%E0%B8%B0%E0%B8%81%E0%B8%B2%E0%B8%A8%E0%B8%84%E0%B8%A7%E0%B8%B2%E0%B8%A1%E0%B8%A3%E0%B9%88%E0%B8%A7%E0%B8%A1%E0%B8%A1%E0%B8%B7%E0%B8%AD%E0%B9%80%E0%B8%9E%E0%B8%B7%E0%B9%88%E0%B8%AD%E0%B8%9E%E0%B8%B1%E0%B8%92%E0%B8%99%E0%B8%B2%E0%B9%81%E0%B8%A5%E0%B8%B0%E0%B8%99%E0%B8%B3-NRX-101-%E0%B9%80%E0%B8%82%E0%B9%89%E0%B8%B2%E0%B8%AA%E0%B8%B9%E0%B9%88%E0%B8%95%E0%B8%A5%E0%B8%B2%E0%B8%94.html
 Neutral

NRX Pharmaceuticals Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide NRX and other traded companies coverage with news coverage. We help investors stay connected with NRX headlines for the 29th of November to make an informed investment decision based on correlating the impacts of news items on NRX Stock performance. Please note that trading solely based on the NRX Pharmaceuticals hype is not for everyone as timely availability and quick action are needed to avoid losses.
NRX Pharmaceuticals' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help NRX Pharmaceuticals investors visualize upcoming and past events in order to time the market based on NRX Pharmaceuticals noise-free hype analysis.
NRX Pharmaceuticals stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the NRX earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about NRX Pharmaceuticals that are available to investors today. That information is available publicly through NRX media outlets and privately through word of mouth or via NRX internal channels. However, regardless of the origin, that massive amount of NRX data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of NRX Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of NRX Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to NRX Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive NRX Pharmaceuticals alpha.

NRX Largest EPS Surprises

Earnings surprises can significantly impact NRX Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-08-15
2022-06-30-0.1-0.11-0.0110 
2023-08-14
2023-06-30-0.14-0.120.0214 
2023-05-15
2023-03-31-0.14-0.16-0.0214 
2023-03-31
2022-12-31-0.14-0.16-0.0214 
2023-11-13
2023-09-30-0.11-0.070.0436 
2024-05-14
2024-03-31-0.55-0.74-0.1934 
View All Earnings Estimates

NRX Pharmaceuticals Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to NRX Pharmaceuticals Stock. Current markets are slightly bearish. About 51% of major world exchanges and indexes are down. See today's market update for more information.
Google News at Macroaxis
20th of November 2024
NRx Pharmaceuticals, Inc. Announces Receipt of Po - GuruFocus.com
at news.google.com 
news
8th of November 2024
NRx Pharmaceuticals Set to Announce Quarterly Earnings on Thursday
at thelincolnianonline.com 
seekingalpha News
21st of October 2024
NRx started at buy by EF Hutton, cites suicide prevention focus
at seekingalpha.com 
Yahoo News
30th of September 2024
NRx Pharmaceuticals, Inc. Announces Completion of Twelve Months of Stability on the First ...
at finance.yahoo.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NRX Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NRX Pharmaceuticals' short interest history, or implied volatility extrapolated from NRX Pharmaceuticals options trading.

Additional Tools for NRX Stock Analysis

When running NRX Pharmaceuticals' price analysis, check to measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.